Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,377,247
-$8,023,586 QoQ
Shares Held
638,590
-23.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#340
of 2,821 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AIA Group Ltd holds $257,927,168 across 9 Drug Manufacturers - General names. PFE ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
313,964 | $79,737,436 | |
| 2 | LLY |
ELI LILLY & Co
|
56,816 | $68,146,820 | |
| 3 | MRK |
Merck & Co., Inc.
|
449,725 | $57,789,662 | |
| 4 | PFE |
Pfizer Inc
This page
|
638,590 | $15,377,247 | |
| 5 | ABBV |
AbbVie Inc.
|
57,308 | $14,420,984 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
149,569 | $8,618,164 | |
| 7 | AMGN |
Amgen Inc
|
21,029 | $7,615,020 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
39,764 | $5,023,783 |
All Filings in PFE
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,377,247 | 638,590 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $23,400,833 | 833,363 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $18,094,332 | 726,680 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $12,313,159 | 483,248 | Shares | Defined | 2025-12-18 | |
| 2025-06-30 | $4,933,882 | 203,543 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $6,292,884 | 248,338 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $5,093,866 | 192,004 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $7,377,992 | 254,941 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $7,564,420 | 270,351 | Shares | Defined | 2024-07-31 | |
| 2024-03-31 | $4,957,454 | 178,647 | Shares | Defined | 2024-05-06 | |
| 2023-12-31 | $2,280,052 | 79,196 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $2,920,220 | 88,038 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $1,959,262 | 53,415 | Shares | Defined | 2023-07-28 | |
| 2023-03-31 | $5,445,127 | 133,459 | Shares | Defined | 2023-04-28 | |
| 2022-12-31 | $8,435,180 | 164,621 | Shares | Defined | 2023-01-31 | |
| 2022-09-30 | $5,132,129 | 117,279 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $10,385,439 | 198,082 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $4,733,641 | 91,436 | Shares | Defined | 2022-05-06 | |
| 2021-12-31 | $3,710,820 | 62,842 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $868,027 | 20,182 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $671,280 | 17,142 | Shares | Defined | 2021-08-03 | |
| 2021-03-31 | $2,033,408 | 56,125 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,303,017 | 62,565 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||